Biotechnology VALUE FUND II L.P., 10% Owner at GLYCOMIMETICS INC (GLYC), bought 3,337,492 shares at $3.18 ($10.6M) on 2019-09-05, disclosed to the SEC on 2019-09-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.18 | 124,956 | $397K | 3.7% |
| 2 | $3.18 | 124,956 | $397K | 3.7% |
| 3 | $3.18 | 689,834 | $2.2M | 20.7% |
| 4 | $3.18 | 689,834 | $2.2M | 20.7% |
| 5 | $3.18 | 853,956 | $2.7M | 25.6% |
| 6 | $3.18 | 853,956 |
| $2.7M |
| 25.6% |
| Total | $3.18 avg | 3,337,492 | $10.6M | 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |